Apotex Asks High Court To Deny Review Of Panel’s Reversal In Patent Drug Suit
(October 29, 2015, 1:01 PM EDT) -- WASHINGTON, D.C. — Apotex Inc. argues in an Oct. 5 opposition brief that the U.S. Supreme Court should not review a drug patent infringement lawsuit over efforts to end a company’s...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login